Jasper Therapeutics Appoints Herb Cross As Chief Financial

Sep 25, 2023•almost 2 years ago

Position

Chief Financial Officer

Company

Jasper Therapeutics

Herb Cross

Redwood CityTherapeuticsBiotechnologyHealth Care

Description

REDWOOD CITY, Calif., Sept. 25, 2023 -- Jasper Therapeutics, Inc. , a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit to address diseases such as chronic spontaneous urticaria , lower to intermediate risk myelodysplastic syndromes as well as novel stem cell transplant conditioning regimens, today announced the appointment of Herb Cross, an experienced senior financial executive, as the company’s Chief Financial Officer

Company Information

Company

Jasper Therapeutics

Location

Redwood City, California, United States

About

Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months